Nissay Asset Management Corp Novavax Inc Transaction History

Nissay Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $283,709 - $588,767	-7,820 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $18,548 - $38,011	266 Added 3.52%	7,820 $576,000
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $73,335 - $118,793	-545 Reduced 6.73%	7,554 $1.08 Million
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $43,027 - $65,480	242 Added 3.08%	8,099 $1.68 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $950,697 - $2.02 Million	7,857 New	7,857 $1.67 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Nissay Asset Management Corp with notifications on news.